Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination : a retrospective cohort study of 16 million people

Taylor, K, Eastwood, S, Walker, V, Cezard, G, Knight, R, Al Arab, M, Wei, Y, Horne, E M F, Teece, L, Forbes, H, Walker, A, Fisher, L, Massey, J, Hopcroft, L E M, Palmer, T, Cuitun Coronado, J, Ip, S, Davy, S, Dillingham, I, Morton, C, Greaves, F, Macleod, J, Goldacre, B, Wood, A, Chaturvedi, N, Sterne, J A C, Denholm, R, Longitudinal Health and Wellbeing and Data and Connectivity UK COVID-19 National Core Studies, CONVALESCENCE study & OpenSAFELY collaborative 2024, 'Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination : a retrospective cohort study of 16 million people', The Lancet Diabetes and Endocrinology, vol. 12, no. 8, pp. 558-568. https://doi.org/10.1016/S2213-8587(24)00159-1